NextFin News - Mitchell Katz, the chief executive of NYC Health + Hospitals, has proposed a radical shift in diagnostic medicine by suggesting that artificial intelligence could handle initial breast cancer screenings across the nation’s largest public hospital system by 2026. The proposal, which would see AI algorithms perform the primary "read" on mammograms, aims to address chronic staffing shortages and the high costs associated with traditional radiology. Under the plan, human radiologists would only intervene when the software flags an abnormality, effectively removing the requirement for a "double-read" by human eyes on thousands of routine scans.
Katz, who has led the $11 billion municipal health system since 2018, is known for his pragmatic, often aggressive approach to fiscal management in "safety-net" healthcare. His tenure has been defined by efforts to stabilize the system’s precarious finances while expanding primary care access for New York’s uninsured. This latest push into AI-first diagnostics follows a massive $224 million investment in GE imaging technology, which Katz argues provides the necessary infrastructure to support automated screening. His stance is rooted in the belief that current AI tools are already capable of identifying "normal" results with high accuracy, allowing human specialists to focus their limited time on complex cases.
The proposal has sparked a sharp divide within the medical community, and it does not yet represent a consensus among healthcare providers or regulators. Proponents, including Sandra Scott of One Brooklyn Health, view the move as a "game-changer" for hospitals operating on razor-thin margins. By automating the bulk of routine screenings, these institutions could theoretically reduce wait times and lower the cost of preventative care. However, the plan faces significant legal and clinical hurdles. Current New York State regulations mandate that a licensed radiologist must review and sign off on all medical imaging studies, a rule Katz is now actively lobbying to change.
Critics have been quick to label the "AI-only" approach as a dangerous cost-cutting measure. Mohammed Suhail of North Coast Imaging described the CEO’s vision as "naive," warning that over-reliance on current technology could lead to missed diagnoses and patient harm. The primary concern among skeptics is the "black box" nature of AI algorithms, which may fail to detect subtle patterns that a trained human eye would catch. Furthermore, the legal liability for a missed diagnosis in an AI-only workflow remains a murky area of medical law that has yet to be tested in the courts.
The financial implications of such a shift are substantial. For a system like NYC Health + Hospitals, which serves over a million New Yorkers annually, the labor savings from automating initial radiology reads could reach tens of millions of dollars. Yet, the transition depends entirely on the willingness of state regulators to grant exceptions to existing medical practice laws. If Katz succeeds in securing these waivers, it could set a precedent for public health systems across the United States, potentially transforming radiology from a labor-intensive specialty into a tech-monitored oversight role.
Explore more exclusive insights at nextfin.ai.
